These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14520139)

  • 1. Use of linezolid in children. Introduction.
    Kaplan SL
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S151-2. PubMed ID: 14520139
    [No Abstract]   [Full Text] [Related]  

  • 2. [Linezolid].
    Yanagihara K; Yanagihara K; Kohno S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():352-9. PubMed ID: 17455645
    [No Abstract]   [Full Text] [Related]  

  • 3. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EUCAST Technical Note on linezolid.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
    [No Abstract]   [Full Text] [Related]  

  • 5. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Linezolid.
    Ann Intern Med; 2003 Jan; 138(2):I44. PubMed ID: 12529109
    [No Abstract]   [Full Text] [Related]  

  • 10. [Linezolid--novel antibiotic for the treatment of gram-positive bacterial infections].
    Jankowski A; Stefanik W
    Wiad Lek; 2006; 59(9-10):727-31. PubMed ID: 17338140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus].
    Klingkowski U; Huth RG; Habermehl P; Knuf M
    Klin Padiatr; 2004; 216(1):21-3. PubMed ID: 14747966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of linezolid in children.
    Kaplan SL
    Pediatr Infect Dis J; 2002 Sep; 21(9):870-2. PubMed ID: 12352813
    [No Abstract]   [Full Text] [Related]  

  • 15. [Linezolid, a drug in a new class of antibiotics].
    Knudsen JD; Skov RL
    Ugeskr Laeger; 2003 Mar; 165(13):1349-53. PubMed ID: 12703280
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment.
    Dryden MS
    J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv7-iv15. PubMed ID: 21521707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid pharmacokinetics in pediatric patients: an overview.
    Jungbluth GL; Welshman IR; Hopkins NK
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid for endocarditis: a case series of 14 patients.
    Tascini C; Bongiorni MG; Doria R; Polidori M; Iapoce R; Fondelli S; Tagliaferri E; Soldati E; Di Paolo A; Leonildi A; Menichetti F
    J Antimicrob Chemother; 2011 Mar; 66(3):679-82. PubMed ID: 21393234
    [No Abstract]   [Full Text] [Related]  

  • 19. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
    Ament PW; Jamshed N; Horne JP
    Am Fam Physician; 2002 Feb; 65(4):663-70. PubMed ID: 11871684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Other antimicrobials (linezolid, quinupristin/dalfopristin)].
    Yamaguchi K; Ohno A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():756-61. PubMed ID: 12722312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.